United States Public Health Service decision no. 6 under Section 63 of Regulations for sale of viruses, serums, toxins, and analogous products (revised).
| Corporate Author: | United States. Public Health Service |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Washington] :
[s.n.],
1936.
|
| Subjects: | |
| Online Access: | Electronic resource (PDF) |
Similar Items
United States Public Health Service decision no. 7 under Section 63 of Regulations for sale of viruses, serums, toxins, and analogous products (revised).
Published: (1937)
Published: (1937)
United States Public Health Service decision no. 4 under Section 63 of Regulations for sale of viruses, serums, toxins, and analogous products (revised).
Published: (1933)
Published: (1933)
Amendment to regulations for sale of viruses, serums, toxins, and analogous products.
Published: (1907)
Published: (1907)
Amendment to regulations for sale of viruses, serums, toxins, and analogous products.
Published: (1906)
Published: (1906)
Amendment to regulations for sale of viruses, serums, toxins, and analogous products.
Published: (1906)
Published: (1906)
Amendment No. 1 to Regulations for sale of viruses, serums, toxins, and analogous products.
Published: (1917)
Published: (1917)
Amendment No. 2 to Regulations for sale of viruses, serums, toxins, and analogous products.
Published: (1927)
Published: (1927)
United States Public Health Service decision 1, under Section 9 of Regulations for control of manufacture, importation, and sale of arsphenamine and its derivatives.
Published: (1938)
Published: (1938)
Regulations for control of manufacture, importation, and sale of arsphenamine and its derivatives, referred to collectively, as arsphenamines.
Published: (1938)
Published: (1938)
Amendment to Paragraph 73 of Regulations for sale of viruses, serums, toxins, and analogous products approved Aug. 1, 1923.
Published: (1932)
Published: (1932)
Amendment to Paragraphs 72 and 73 of Regulations for sale of viruses, serums, toxins, and analogous products approved Aug. 1, 1923.
Published: (1928)
Published: (1928)
Regulations for the Sale of Viruses, Serums, Toxins, and Analogous Products, In the District of Columbia and Interstate Traffic, Approved Oct. 12, 1940.
Published: (1941)
Published: (1941)
Regulations for sale of viruses, serums, toxins, and analogous products in D.C. and in interstate traffic.
Published: (1909)
Published: (1909)
Amending act to regulate sale of viruses, serums, toxins, and analogous products in the District of Columbia.
Published: (1937)
Published: (1937)
Regulations for sale of viruses, serums, toxins, and analogous products in D.C., et cetera.
Published: (1903)
Published: (1903)
Regulations for sale of viruses, serums, toxins, and analogous products in D.C. and in interstate traffic.
Published: (1909)
Published: (1909)
The Virus, Serum, and Toxin Act.
Published: (1916)
Published: (1916)
Revised Form 1922-B (edition May 1921).
Published: (1921)
Published: (1921)
Laws and Comptroller's decisions pertaining to U.S. Public Health Service.
Published: (1922)
Published: (1922)
Amendment No. 6 to U.S. quarantine regulations, Public Health Service.
Published: (1923)
Published: (1923)
Legal and ethical concerns in medicine.
Regulations governing preparation, sale, barter, exchange, shipment, and importation of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1913)
Published: (1913)
Regulations governing preparation, sale, barter, exchange, shipment, and import of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1922)
Published: (1922)
Regulations governing preparation, sale, barter, exchange, shipment, and import of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1932)
Published: (1932)
Regulations governing preparation, sale, barter, exchange, shipment, and importing of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1930)
Published: (1930)
Regulations governing preparation, sale, barter, exchange, shipment, and importation of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1919)
Published: (1919)
Regulations governing preparation, sale, barter, exchange, shipment, and importation of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1930)
Published: (1930)
Regulations governing preparation, sale, barter, exchange, shipment, and importing of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1931)
Published: (1931)
Regulations governing preparation, sale, barter, exchange, shipment, and importation of viruses, serums, toxins, and analogous products intended for use in treatment of domestic animals.
Published: (1929)
Published: (1929)
Importation of viruses, serums, toxins, etc.
Published: (1916)
Published: (1916)
Brackenridge's Medical Selection of Life Risks /
Published: (2006)
Published: (2006)
Amendment to regulations, U.S. Public Health Service.
Published: (1912)
Published: (1912)
Virus-Serum-Toxin Act : A Brief History and Analysis.
Published: (2005)
Published: (2005)
Regulations for enforcement of Federal Food and Drugs Act (10th revision).
Published: (1937)
Published: (1937)
Amendment No. 1 to U.S. quarantine regulations, Public Health Service.
Published: (1920)
Published: (1920)
Amendment No. 5 to U.S. quarantine regulations, Public Health Service.
Published: (1923)
Published: (1923)
Amendment No. 8 to U.S. quarantine regulations, Public Health Service.
Published: (1925)
Published: (1925)
Amendment No. 7 to U.S. quarantine regulations, Public Health Service.
Published: (1923)
Published: (1923)
FDA User Fees 2012 : Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development, and Downstream Pharmaceutical Supply Chain.
Published: (2012)
Published: (2012)
Regulation of Sale of Viruses, Serums, Toxins and Analogous Products, etc : hearings before the United States House Committee on the District of Columbia, Sixty-Eighth Congress, first session, on Feb. 21, 25, Mar. 3, 24, Apr. 30, May 6, 1924.
Published: (1924)
Published: (1924)